PrivCo Logo

Mark Cuban’s Cost Plus Drug Company

Mark Cuban’s Cost Plus Drug Company
June 23, 2022

The Daily Stack is a daily private market insights newsletter by PrivCo, a private company intelligence platform. Read our previous insights.
If you have friends who would enjoy reading this newsletter, please forward this email to them.

Full disclosure: I am a longtime fangirl of Mark Cuban. As an avid viewer of Shark Tank, I am always struck by how he is tough but fair, an occasionally warm-hearted business person. He’s a lovable brother, with smart older brother vibes.

Taking notes on what other billionaire business leaders do for passion projects, one would think the best thing to do with all that wealth is to plot for space domination (Musk, Bezos, Branson), build a better alternate reality (Zuckerberg), or achieve immortality (Thiel). But Cuban isn’t like other billionaires.

Mark Cuban’s Cost Plus Drug Company is out to make prescription medications more affordable. The company does so by cutting out the middleman and delivering lifesaving generic pharmaceuticals to patients via a straightforward e-commerce platform.

The cut-out-the-middleman strategy
Hello? Why has no one started this company before? Direct-to-consumer has proven useful for offering customers lower prices for years. Warby Parker, Italic, and Everlane come immediately to mind. But prescription drugs? That’s an industry “ripe for disruption.” GoodRX, Capsule, and Honeybee Health are several of the available options already on the market, but Cuban’s offering is poised to manufacture, distribute, and negotiate with all the pizzazz that made Mark Cuban a billionaire.

Billionaire Ambassador
In this case, it wasn’t Mark Cuban who came up with the idea, but Dr. Alex Oshmyansky, who founded the company in 2018 as Osh Affordable Pharmaceuticals. Cuban came on as a backer, and the rest is history. A recently published study found that Medicare could have saved nearly $4BN in 2020 if it purchased drugs from Cuban’s pharmacy. The policy still lags in order to make that savings a reality, but with drug savings of over $2,400 for cancer medications, this idea is a win for consumers.

Is Mark Cuban virtuous? Maybe, but he’s also out to gain. Can he do it with Cost Plus? Stay tuned.

You're hired. Not!
Job offers are getting rescinded as more companies tighten budgets.
Slack for the Zoom generation
Slack attempts to recreate water cooler chat with new video hang feature.
[The Verge]

Since last week, PrivCo has added:
2,270 Companies | 262 Funding Activities | 135 M&A Deals

Funding & Deal Highlights:

Stashfin raises $70MM from Uncorrelated

Fintech • Round C • New Delhi, India

LeadSquared raises $153MM from Westbridge

API • Round C • Bangalore, India

Impossible Mining raises $10.1MM from Justin Hamilton

Robotics • Seed • San Jose, CA

Neuron 7 raises $10MM from Battery Ventures

Software • Round A • San Jose, CA


Share Mobility raises $12MM from Iron Gate

Software • Round A • Columbus, OH

Bardeen raises $15.3MM from Insight Partners

Automation • Round A • San Francisco, CA

Carbon Biosciences raises $38MM from Agent

Biotechnology • Round A • Lexington, MA

Hai Robotics raises $100MM from Capital

Robotics • Round D • Shenzhen, China

Omio raises $80MM from Lazard Asset Management

SaaS • Round E • Berlin, Germany

Openly raises $75MM from Advance Venture Partners

Insurance • Round C • Boston, MA

Mondelez announces acquisition of Clif Bar

Snacks • Acquisition • Emeryville, CA

Qualcomm acquires Cellwize Wireless

Technology • Acquisition • Southlake, TX

Forward to a Friend Forward to a Friend
Not a subscriber yet? Sign up here!
Have an interesting topic you want us to include. Let us know!
Copyright © 2022 PrivCo Media, LLC. All Rights Reserved.
Unsubscribe | | Contact Us
PrivCo Logo

© 2024 PrivCo Media, LLC


HomeSign inContactPricing